Purpose of establishment
In the 21st century, the greatest ” Longevity Industry” is approaching, and mankind will enter the era of longevity. VitaSpring aims to build a cell medical industry, invest in research and development of stem cell applications in regenerative medicine, establish advanced medical research centers and high standard cell production centers, and provide “GTP” standard stem cell preparations for the development of cellular drugs. Through the development of cell medicine, it will become a leading international business group in the fields of regenerative medicine applied to the innovative fields of medicine, preventive health care, beauty, and anti-aging. The “GTP Cell Center” is basis for its business, which is cross-domain in biotechnology medical treatment, medicine and medical materials, and focuses on the development of cell medical treatment
Introduction of X.msc
X.msc originates from the placenta. The placenta is a tissue or organ formed by the birth of a baby. The ancient Chinese regarded it as a car from the Galaxy born with babies, and its color was purple-red, so it was called “Zi he che” (means purple river car), and it was also called afterbirth. Its structure is composed of cells derived from infant genes, and also derived from mother gene cells. It has a large number of stem cell clusters with different functions. During
pregnancy, the placenta is stabilized in the endometrium and peeled off during production, nutrients and excretion are exchanged in the meantime, and many growth factors are provided to assist in growth. An important stem cell in the structure is derived from the other’s gene, has a special structure and is located in a specific location, responsible for important functions.
Due to the special functional expression, it cannot be vaguely referred to as placental chorionic mesenchymal stem cells (pcMSC), which is isolated from its many pcMSCs, and we named it X.msc. X indicates the maternal gene, symbolizing its particularity, developmental and futuristic. The exosome produced by it is called X.exosome, and it also responds to the development of many special functions and multiple applications, and plays an important role in cell medicine, medical beauty, and longevity health care.
- Headquarters in the United States:
Invest in core business entities and their derivative businesses; business cooperation mainly engages in the development of international markets, technical cooperation, research and development cooperation ⋯
- GTP cell center in Taiwan:
Produces “X.msc” stem cells (specific to placenta) and X.exosome as two main spindle products. These two products are produced simultaneously, one for cells and one for culture! GTP Cell Center produces stem cell preparations for human clinical trials of cell medical treatment, future patented cell medicines, and cell preparations for longevity health care and longevity medical beauty…
- New drug R & D company in Taiwan
The research and development company invests in the development of cell drugs and entered clinical trials. The first eight projects of new cell drugs development will obtain IND license of the US FDA in 2020.
- Foresight R & D Foundation in the United States:
Get In touch
available from 10:00 – 19:00
Address 2372 Morse Ave, #950 Irvine, CA 92614 U.S.A.